Abstract 13276: FoxO4 Promotes Post Myocardial Infarction Left Ventricular Remodeling

Min Zhu,Sydney Morris,Zhi‐Ping Liu

IF: 37.8

2013-01-01

Circulation

Abstract:Myocardial infarction (MI) can result in a maladaptive remodeling of left ventricles (LV) that leads to LV dysfunction and eventual heart failure. Forkhead box O transcription factors (FoxO1, O3, a...

What problem does this paper attempt to address?

Abstract 261: Foxo4 Promotes Early Inflammatory Response Upon Myocardial Infarction Via Endothelial Arg1

Min Zhu,Zhaoning Wang,Robert Z. Luo,Sean C. Goetsch,Jay W. Schneider,Joseph A. Hill,Sidney E. Morris,Zhiping Liu

DOI: https://doi.org/10.1161/res.117.suppl_1.261

IF: 23.213

2015-01-01

Circulation Research

Abstract:Myocardial infarction (MI) can result in a maladaptive remodeling of the heart that leads to heart failure. The post-MI inflammation is necessary for wound healing. Unfortunately it is also a key component of subsequent heart failure pathology. Thus, understanding the mechanism of post-MI inflammation and identifying targets for intervention are of translational interests. To understand the role of FoxO4 in post-MI remodeling, we induced MI in WT and FoxO4 global knockout ( gKO ) mice by surgical ligation of the left anterior descending coronary artery. FoxO4- inactivation resulted in a significantly higher post-MI survival, better cardiac function, and reduced fibrosis and infarct size compared to WT mice. FoxO4 gKO mouse hearts had significantly less mount of neutrophils, and reduced expressions of cytokines, MMP9, and Arginase 1 (Arg1). To determine the contribution of cellular FoxO4 to the post-MI phenotype, we generated cardiomyocyte and endothelial cell specific FoxO4 knockout mice ( FoxO4 cKO and eKO ). While FoxO4 cKO mice showed similar post-MI phenotype to those of WT littermates, FoxO4 eKO mice had better cardiac function with reduced inflammation, neutrophil infiltration, and Arg1 expression similar to those of FoxO4 gKO mice. Since Arg1 is a competitive inhibitor of nitric oxide (NO) synthase and NO inhibits lymphocyte adhesion and transmigration across the endothelial barrier, downregulation of neutrophils in post-MI FoxO4- null mouse hearts could be due to reduced endothelial Arg1 and thus increased NO. Consistent with this hypothesis, we show that Arg1 is a direct transcriptional target of FoxO4. Endothelial FoxO4 is necessary and sufficient to activate Arg1 expression in response to hypoxia. Knockdown of FoxO4 in human aortic endothelial cells suppressed leukocyte adhesion. Furthermore, chemical inhibition of Arg1 in WT mice had similar cardioprotection following MI as FoxO4- inactivation and administration of NOS inhibitor to FoxO4 gKO mice reversed the beneficial effects of FoxO4 -deletion on post-MI cardiac function. Our studies showed that FoxO4 promotes early inflammatory response via endothelial Arg1 and suggest a potential therapy to reduce the early post-MI inflammation and enhance cardiac function in MI-injured hearts.
The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction

C Skurk,Z Karadeniz,P Schenkenberger,H Maatz,E Lindberg,T Haase,A Thiele,N Kraenkel,M Taupitz,U Kintscher,J Kurreck,W Poller,C Scheibenbogen,U Landmesser,N Huebner

DOI: https://doi.org/10.1093/eurheartj/ehae666.828

IF: 39.3

2024-10-29

European Heart Journal

Abstract:Background Myofibroblast and myeloid cell differentiation following acute myocardial infarction (MI) are important for myocardial fibrosis but also cause adverse remodeling leading to cardiac dysfunction and heart failure. The transcription factor forkhead box O 3 (Foxo3) inhibits hypertrophic cardiac remodeling. We hypothesized that Foxo3, a key regulator of cell differentiation and immunity might inhibit differentiation of fibroblasts and myoloid cells and therefore cardiac fibrosis after MI. Methods MI was induced in Foxo3-/- and wild-type mice by permanent LAD ligation. Cardiac function was determined by transthoracic echocardiography. Cell differentiation was investigated by single nucleus RNA-sequencing (snRNA-seq). Moreover, transdifferentiation assays ex vivo were performed. Results Foxo3-/- mice showed significantly improved survival post- MI (p<0.01) that was in part due to reduced cardiac ruptures (p<0.05). TTE showed reduced LV function, cardiac output, and global strain 4 days post-MI in both groups of animals. However, LV function was significantly attenuated in Foxo3-/- mice 14 d post-MI while diastolic parameters indicated enhanced wall stiffness. snRNA-seq on day 4 post-MI revealed significantly increased numbers of myofibroblasts (p<0.05) transdifferentiating from Progenitor-like state fibroblasts and epicardial derived fibroblasts in Foxo3-/- mice. Myofibroblasts upregulated genes important for extracellular matrix structure and cell migration. Moreover, an upregulation of pro-fibrotic genes was observed in other fibroblast clusters in Foxo3-/- mice and corroborated by significantly elevated collagen type 1 and 3 as well as periostin protein expression. Mechanistically, fibroblasts from Foxo3a-/- mice exhibited enhanced Smad3 dependent myofibroblast marker expression after TGF-ß stimulation. Cell chat analysis indicated enhanced number of interactions and interaction strength of myeloid cells with fibroblasts in Foxo3-/- animals. In line with these observations, differences in cardiac myeloid cell differentiation characterized by reduced center-log ratios of cardiac resident macrophages (Lyve1hiMHCIIlo and Lyve1loMHCIIhi) and increase in monocyte-derived macrophages (Ccr2hi MΦ and Trem2hi MΦ) on day 4 post-MI that was enhanced in Foxo3-/- mice were determined. Differential gene expression patterns on day 4 in pro-inflammatory macrophages (Ccr2hi MΦ) showed upregulation of genes in the interleukin-12 pathway while reparative macrophages (Trem2hi MΦ) revealed an increased expression of genes for extracellular matrix proteins and ECM-collagen interactions in Foxo3-/- mice. Conclusion Our data identify Foxo3 as a master regulator of cardiac remodeling inhibiting myofibroblast and myeloid cell differentiation after acute MI, and suggesting that deficiency of Foxo3 promotes early scar formation but also contributes to adverse matricellular remodeling resulting in impaired cardiac function and enhanced fibrosis.

cardiac & cardiovascular systems
Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Lie Liu,Tao Zhuang,Jingjiang Pi,Xiaoli Chen,Qi Zhang,Ying Li,Haikun Wang,Yajing Shen,Brian Tomlinson,Paul Chan,Zuoren Yu,Yu Cheng,Xiangjian Zheng,Muredach Reilly,Edward Morrisey,Lin Zhang,Zhongmin Liu,Yuzhen Zhang

DOI: https://doi.org/10.1161/circulationaha.119.039767

IF: 37.8

2019-01-01

Circulation

Abstract:Background: Pathological cardiac fibrosis and hypertrophy, the common features of left ventricular remodeling, often progress to heart failure. Forkhead box transcription factor P1 (Foxp1) in endothelial cells (ECs) has been shown to play an important role in heart development. However, the effect of EC-Foxp1 on pathological cardiac remodeling has not been well clarified. This study aims to determine the role of EC-Foxp1 in pathological cardiac remodeling and the underlying mechanisms. Methods: Foxp1 EC-specific loss-of-function and gain-of-function mice were generated, and an angiotensin II infusion or a transverse aortic constriction operation mouse model was used to study the cardiac remodeling mechanisms. Foxp1 downstream target gene transforming growth factor-beta 1 (TGF-beta 1) was confirmed by chromatin immunoprecipitation and luciferase assays. Finally, the effects of TGF-beta 1 blockade on EC-Foxp1 deletion-mediated profibrotic and prohypertrophic phenotypic changes were further confirmed by pharmacological inhibition, more specifically by RGD-peptide magnetic nanoparticle target delivery of TGF-beta 1-siRNA to ECs. Results: Foxp1 expression is significantly downregulated in cardiac ECs during angiotensin II-induced cardiac remodeling. EC-Foxp1 deletion results in severe cardiac remodeling, including more cardiac fibrosis with myofibroblast formation and extracellular matrix protein production, as well as decompensated cardiac hypertrophy and further exacerbation of cardiac dysfunction on angiotensin II infusion or transverse aortic constriction operation. In contrast, EC-Foxp1 gain of function protects against pathological cardiac remodeling and improves cardiac dysfunction. TGF-beta 1 signals are identified as Foxp1 direct target genes, and EC-Foxp1 deletion upregulates TGF-beta 1 signals to promote myofibroblast formation through fibroblast proliferation and transformation, resulting in severe cardiac fibrosis. Moreover, EC-Foxp1 deletion enhances TGF-beta 1-promoted endothelin-1 expression, which significantly increases cardiomyocyte size and reactivates cardiac fetal genes, leading to pathological cardiac hypertrophy. Correspondingly, these EC-Foxp1 deletion-mediated profibrotic and prohypertrophic phenotypic changes and cardiac dysfunction are normalized by the blockade of TGF-beta 1 signals through pharmacological inhibition and RGD-peptide magnetic nanoparticle target delivery of TGF-beta 1-siRNA to ECs. Conclusions: EC-Foxp1 regulates the TGF-beta 1-endothelin-1 pathway to control pathological cardiac fibrosis and hypertrophy, resulting in cardiac dysfunction. Therefore, targeting the EC-Foxp1-TGF-beta 1-endothelin-1 pathway might provide a future novel therapy for heart failure.
Abstract We130: Novel Role of RBFox1 in Myocardial Infarction Induced Heart Failure

Mengying He,Cansheng Zhu,Nkechi Onubogu,Caitlin Keezer,Xingyu He,Yigang Wang,Xinyang Hu,Shuyuan Sheng,Yibin Wang,chen gao

DOI: https://doi.org/10.1161/res.135.suppl_1.we130

IF: 23.213

2024-01-01

Circulation Research

Abstract:Introduction: Alternative mRNA splicing affects a broad spectrum of cardiac genes during pathological manifestation of heart diseases. Earlier studies from our lab have identified a muscle-specific isoform of RBFox1 to be a key RNA splicing regulator in pressure overload induced heart failure through regulating cardiac transcription factor alternative splicing. However, the physiological impact of RBFox1 in myocardial infarction (MI), and the RBFox1 downstream mRNA alternative splicing events during MI induced cardiac remodeling remains unknown. Goals: To investigate the functional impact of RBFox1 in MI induced cardiac remodeling. Method and Results: At both mRNA and protein levels, we found RBFox1 to be significantly decreased in Sprague-Dawley Rat hearts post MI. To investigate the functional impact of RBFox1 in myocardial infarction, we utilized AAV9 to achieve cardiac specific expression of RBFox1 in rats. Interestingly, expression of RBFox1 prevented cardiac dysfunction post MI characterized by improved cardiac function based on echocardiography. Expression of RBFox1 further reduced hypertrophy, cell death and fibrotic remodeling at both molecular and histological levels post MI. In vitro, expression of RBFox1 is sufficient to prevent hypoxia induced cardiac cell death based on TUNEL staining and cleaved caspase 3 level, while inactivation of RBFox1 promoted cardiac cell death. To further understand the molecular mechanism underlying RBFox1 mediated cardiac protection, we performed RNA-seq analysis to determine the transcriptome changes in vivo. RNA-seq showed insulin secretion, cAMP signaling and muscle contraction pathways to be top significantly changed pathways in RBFox1 expressed rat hearts post MI. Lastly, we have identified Mbnl1 mRNA alternative splicing to be regulated by RBFox1 through promoting a 36bp exon exclusion at the C-terminal of Mbnl1 protein, potentially affecting the function of Mbnl1. Conclusion: In summary, we have identified a previously uncharacterized role of RBFox1 in myocardial infarction injury. RBFox1 expression is critical to preserve cardiac function post MI, potentially through regulating downstream targets alternative splicing, including Mbnl1.
Abstract 13152: Endothelial Foxp1 Regulates Cardiac Fibrosis Via Endothelial-To-Mesenchymal Transition

Jie Liu,Tao Zhuang,Xiaoli Chen,Yashu Kuang,Yanfang Wang,Lin Zhang,Yuzhen Zhang

IF: 37.8

2019-01-01

Circulation

Abstract:Introduction: Pathological cardiac fibrosis is a common feature of left ventricular remodeling and often progresses towards heart failure. Endothelial-to-mesenchymal transition (EndoMT) was reporte...
Abstract 516: Endothelial Foxp1 Regulates Cardiac Remodeling Via Tgfbeta and Et-1 Signal Pathway

Jie Liu,Tao Zhuang,Xiaoli Chen,Jinjiang Pi,Yashu Kuang,Sheng Peng,Lin Zhang,Yuzhen Zhang

DOI: https://doi.org/10.1161/atvb.38.suppl_1.516

2018-01-01

Arteriosclerosis Thrombosis and Vascular Biology

Abstract:Rationale: Cardiac fibrosis and hypertrophy is common features in left ventricular remodeling that leads to heart failure. Forkhead box protein P-1 (Foxp1), a large modular transcriptional repressor that binds to DNA via the highly conserved forkhead DNA-binding domain, is crucial in coordinating the balance of cardiomyocyte proliferation and differentiation through cell lineage-specific regulation during cardiac development. However, its role in adult pathological cardiac remodel remains to be clarified. Objective: We seek to determine the role and the underlying mechanisms of Foxp1 in cardiac fibrosis and hypertrophy. Methods and Results: Foxp1 was highly expressed in endocardium and cardiac microvascular endothelial cells, significantly reduced following AngII stimulation. Loss of endothelial Foxp1 increased AngII-mediated cardiac fibrosis, which was accompanied by myofibroblast proliferation and endothelial-mesenchymal transition (endMT) with elevated expression of fibrotic matrix genes. TGF-β signal pathway was identified as Foxp1 direct downstream target gene in endothelial cells to regulate the fibrosis. Increased AngII-mediated cardiac hypertrophy was observed when loss of endothelial Foxp1, with elevated cardiac hypertrophic genes and fetal myosin gene (myh7) expression but reduced adult mature myosin gene (myh6) expression via endothelial ET-1 signal. The pathological remodel in endothelial Foxp1 deficient mutant mice finally led to worsen cardiac diastolic dysfunction as shown by elevated E/e’ ratio in echocardiogram. Moreover, the similar pathological remodel and worsen cardiac diastolic and systolic dysfunction as shown by reduction of LV fractional shortening (FS) and ejection fraction (EF) were observed in pressure overload transverse aortic constriction (TAC) model when loss of endothelial Foxp1. Conclusions: This study uncovered a previously unrecognized anti-fibrotic and anti-hypertrophic role of Foxp1 in pathological cardiac remodel, which is achieved through the regulation of endothelial TGF-β/ET-1 signals, implying the promising therapeutic targets in pathological cardiac remodeling diseases and heart failure.
Abstract 15392: Exosomal Microrna 486-5P Mediates Cardiac Angiogenesis Post Myocardial Infarction by Targeting MMP19 in Fibroblasts

Xinyang Hu,Qingju Li,Yinchuan Xu,Jianan Wang

IF: 37.8

2019-01-01

Circulation

Abstract:Background: Neovascularization is a pivotal factor to improve cardiac performance recovery from injury induced by myocardial infarction (MI). Exosomes secreted by stem cells, due to their unique pr...
Myoblast Transplantation Improves Cardiac Function after Myocardial Infarction Through Attenuating Inflammatory Responses.

Bo Wang,Likui Zhang,Hao Cao,Junqi Yang,Manya Wu,Yali Ma,Huimin Fan,Zhenzhen Zhan,Zhongmin Liu

DOI: https://doi.org/10.18632/oncotarget.18244

2017-01-01

Oncotarget

Abstract:Myocardial infarction (MI) is a highly prevalent cardiac emergency, which results in adverse cardiac remodeling and then exacerbates progressive heart failure. Inflammatory responses in cardiac tissue after MI is necessary for myocardium repair and wound healing. However, the excessive inflammation is also a key component of subsequent heart failure pathology. Myoblast transplantation after MI have been fulfilled attractive effects on cardiac repair, but the complications of transplantation and the underlying mechanisms have not been fully elucidated. Here, we found that human myoblast transplantation into minipig myocardium decreased the infiltration of inflammatory cells, the expression levels of many pro-inflammatory genes and the activation of inflammation-related signal pathways, while upregulated the expression levels of anti-inflammatory genes such as IL-10 in cardiac tissue of minipig post-MI, which was contributed to the improved cardiac function, the decreased infarct area and the attenuated myocardial fibrosis. Moreover, co-culture of human myoblasts inhibited the production of IL-1 beta and TNF-alpha as well as activation of MAPK and NF-kappa B signaling pathway induced by damage-associated molecular patterns such as HMGB1 and HSP60 in human THP-1 cells, which was partially attributed to the up-regulated production of IL-10. Collectively, these results indicate that myoblast transplantation ameliorates heart injury and improves cardiac function post-MI through inhibiting the inflammatory response, which provides the novel mechanism for myoblast transplantation therapy of MI.
Abstract 14348: Deleterious Effect of IL-23/IL-17A Axis and Γδt Cells in Left Ventricular Remodeling after Myocardial Infarction in Rodent

Xiaoxiang Yan,Takashi Shichita,Yoshinori Katsumata,Tomohiro Matsuhashi,Hideyuki Ito,Kentaro Ito,Atsushi Anzai,Jin Endo,Yuichi Tamura,Kensuke Kimura,Jun Fujita,Ken Shinmura,Weifeng Shen,Akihiko Yoshimura,Keiichi Fukuda,Motoaki Sano

IF: 37.8

2012-01-01

Circulation

Abstract:Background: Left ventricular (LV) remodeling leads to chronic heart failure and is a main determinant of morbidity and mortality after myocardial infarction (MI). At the present time, ther...
FOXO3a Induces Myocardial Fibrosis by Upregulating Mitophagy

Dongsheng Lin,Hui Luo,Bo Dong,Zhongchun He,Lixia Ma,Zhaofei Wang,Xianliang Wu,Qian Sui

DOI: https://doi.org/10.31083/j.fbl2902056

IF: 3.1

2024-02-05

Frontiers in Bioscience-Landmark

Abstract:BACKGROUND: Atrial fibrillation is one of the most common cardiac arrhythmias. Myocardial fibrosis is closely associated with atrial remodeling, which leads to heightened risk of atrial fibrillation. This study aimed to explore whether forkhead box protein O3 (FOXO3a) impacts myocardial fibrosis incidence by regulating mitophagy.METHODS: Cell viability was assessed by cell counting kit-8 (CCK-8) assays. The expression of vimentin and cytochrome C was detected by immunofluorescence assays. Quantitative real-time polymerase chain reaction (PCR) was used to analyze the relative mRNA level of FOXO3a. Expression of FOXO3a, phosphorylated FOXO3a, Collagen I, Collagen III, alpha-smooth muscle actin (α-SMA), matrix metalloprotease 9 (MMP9), light chain 3 (LC3), phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), Parkin, and sequestosome-1 (p62) proteins were determined by western blotting. 5-ethynyl-2'-deoxyuridine (EDU) incorporation was employed to measure cell proliferation. Changes in mitochondrial membrane potential were determined by 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-imidacarbocyanine iodide (JC-1) staining. A wound healing assay was used to examine cell migration, and the levels of reactive oxygen species were determined by flow cytometry.RESULTS: The expression of FOXO3a was upregulated in cardiac fibroblasts treated with angiotensin II (AngII), while the expression of phosphorylated FOXO3a was downregulated under these conditions. FOXO3a knockdown significantly inhibited the proliferation, migration and collagen secretion of cardiac fibroblasts treated with AngII. The ratio of LC3 II/I as well as expression of PINK1 and Parkin was increased, and the expression of p62 was decreased, in cardiac fibroblasts treated with AngII. Moreover, these effects were limited by FOXO3a knockdown. Finally, the mitophagy inducer everolimus (RAD001) attenuated the suppressive effect of FOXO3a knockdown on cardiac fibroblast activation.CONCLUSIONS: FOXO3a promotes the progress of myocardial fibrosis by triggering mitophagy in cardiac fibroblasts.

cell biology,biochemistry & molecular biology
Abstract 20446: Loss of Mir-144 Signaling Interrupts Extracellular Matrix Remodeling after Myocardial Infarction Leading to Worsened Cardiac Function

Quan He,Fangfei Wang,Takashi Honda,Jing Li,Andrew N. Redington

IF: 37.8

2017-01-01

Circulation

Abstract:Introduction: We have previously shown that MicroRNA (miR) -144 is a key component of the acute cardioprotection associated with remote ischemic preconditioning, but little is known about its effec...
Abstract 15699: Matrix Metalloproteinase-9 Overexpression in Macrophages Improves Ventricular Function by Regulating the Inflammatory and Fibrotic Responses Post-Myocardial Infarction

Rogelio Zamilpa,Trevi A. Ramirez,Jessica Ibarra,Qiuxia Dai,Tariq Dayah,Nguyen,Jianhua Zhang,Seema S. Ahuja,Jeanine D’Armiento,Yufang Jin,Merry L. Lindsey

IF: 37.8

2011-01-01

Circulation

Abstract:Macrophage activation post-myocardial infarction (MI) influences the extent of left ventricular remodeling. Post-MI, activated macrophages infiltrate into the injured myocardium to provide a robust...
The Structure-Function Remodeling In Rabbit Hearts Of Myocardial Infarction

Haotian Wu,Li Li,Pei Niu,Xu Huang,Jinyi Liu,Fengshun Zhang,Wenzeng Shen,Wenchang Tan,Yiling Wu,Yunlong Huo

DOI: https://doi.org/10.14814/phy2.13311

2017-01-01

Physiological Reports

Abstract:Animal models are of importance to investigate basic mechanisms for ischemic heart failure (HF). The objective of the study was to create a rabbit model through multiple coronary artery ligations to investigate the postoperative structure-function remodeling of the left ventricle (LV) and coronary arterial trees. Here, we hypothesize that the interplay of the degenerated coronary vasculature and increased ventricle wall stress relevant to cardiac fibrosis in vicinity of myocardial infarction (MI) precipitates the incidence and progression of ischemic HF. Echocardiographic measurements showed an approximately monotonic drop of fractional shortening and ejection fraction from 40% and 73% down to 28% and 58% as well as persistent enlargement of LV cavity and slight mitral regurgitation at postoperative 12weeks. Micro-CT and histological measurements showed that coronary vascular rarefaction and cardiac fibrosis relevant to inflammation occurred concurrently in vicinity of MI at postoperative 12weeks albeit there was compensatory vascular growth at postoperative 6weeks. These findings validate the proposed rabbit model and prove the hypothesis. The post-MI rabbit model can serve as a reference to test various drugs for treatment of ischemic HF.
A Novel Anti-inflammation and Anti-fibrosis Agent, Vcp979, Treatment Attenuates Ventricular Remodeling and Improves Cardiac Function in Murine Model of Myocardial Ischemia/Reperfusion Injury

Bing H. Wang,Jing Liu,Qingshu Meng,Hao Cao,Xiaoting Liang,Rulin Zhuang,Xinyu Ge,Fang Lin,Kevin W. Huang,Huimin Fan,Peter Scammells,Xiaohui Zhou,Zhongmin Liu

IF: 37.8

2019-01-01

Circulation

Abstract:Introduction: Myocardial ischemia/reperfusion (MI/R) injury results in persistent ventricular remodeling with no effective treatment leading to cardiac functional decline and eventually progression...
Deleterious Effect of the Il-23/Il-17a Axis and Gamma Delta T Cells on Left Ventricular Remodeling after Myocardial Infarction

Xiaoxiang Yan,Takashi Shichita,Yoshinori Katsumata,Tomohiro Matsuhashi,Hideyuki Ito,Kentaro Ito,Atsushi Anzai,Jin Endo,Yuichi Tamura,Kensuke Kimura,Jun Fujita,Ken Shinmura,Weifeng Shen,Akihiko Yoshimura,Keiichi Fukuda,Motoaki Sano

DOI: https://doi.org/10.1161/jaha.112.004408

IF: 6.106

2012-01-01

Journal of the American Heart Association

Abstract:Background-Left ventricular (LV) remodeling leads to chronic heart failure and is a main determinant of morbidity and mortality after myocardial infarction (MI). At the present time, therapeutic options to prevent LV remodeling are limited.Methods and Results-We created a large MI by permanent ligation of the coronary artery and identified a potential link between the interleukin (IL)-23/IL-17A axis and gamma delta T cells that affects late-stage LV remodeling after MI. Despite the finsinf that infarct size 24 hours after surgery was similar to that in wild-type mice, a deficiency in IL-23, IL-17A, or gamma delta T cells improved survival after 7 days, limiting infarct expansion and fibrosis in noninfarcted myocardium and alleviating LV dilatation and systolic dysfunction on day 28 post-MI. M-1 macrophages and neutrophils were the major cellular source of IL-23, whereas >90% of IL-17A-producing T cells in infarcted heart were CD4(-) TCR gamma delta(+) (gamma delta T) cells. Toll-like receptor signaling and IL-1 beta worked in concert with IL-23 to drive expansion and IL-17A production in cardiac gamma delta T cells, whereas the sphingosine-1-phosphate receptor and CCL20/CCR6 signaling pathways mediated gamma delta T cell recruitment into infarcted heart. IL-17A was not involved in the acute inflammatory response, but it functioned specifically in the late remodeling stages by promoting sustained infiltration of neutrophils and macrophages, stimulating macrophages to produce proinflammatory cytokines, aggravating cardiomyocyte death, and enhancing fibroblast proliferation and profibrotic gene expression.Conclusions-The IL-23/IL-17A immune axis and gamma delta T cells are potentially promising therapeutic targets after MI to prevent progression to end-stage dilated cardiomyopathy.
FoxO 4 Promotes Myocardial Ischemia-Reperfusion Injury : the Role of Oxidative Stress-Induced Apoptosis

Lingling Yu,Weifang Zhang,Chahua Huang,Qian Liang,Huihui Bao,Zhijian Gong,Minxuan Xu,Zhenzhen Wang,Minhua Wen,Xiaoshu Cheng

2018-01-01

Abstract:Myocardial cell apoptosis is the main pathophysiological process underlying ischemia-reperfusion (I/R) injury. FoxO4, which was initially identified as a tumor suppressor that limits cell proliferation and induces apoptosis, plays diverse roles in cardiovascular diseases. However, its contribution to myocardial I/R injury remains unclear. The present study was undertaken to explore the role of FoxO4 in apoptosis during myocardial I/R injury and its underlying mechanisms in vivo. Rats were subjected to ligation/restoration of the left anterior descending branch of the coronary artery and 30 min of ischemia, followed by 4 h of reperfusion. Then, triphenyltetrazolium chloride (TTC) staining was performed to evaluate the infarct size. Transthoracic echocardiography was performed to evaluate cardiac function. Terminal deoxynucleotide transferase-mediated dUTP nick end-labeling (TUNEL) staining was performed to assess cell death in the myocardium. Real-time PCR was performed to measure FoxO4 mRNA expression. Western blots were performed to assess expression levels of the FoxO4 and cleaved caspase 3 proteins. Immunofluorescence staining was performed to measure cleaved caspase 3 expression levels. The hydroxylamine and TBA methods were performed to evaluate malondialdehyde (MDA) levels and superoxide dismutase (SOD) activity, respectively. Dihydroethidium (DHE) staining was performed to measure reactive oxygen species (ROS) generation. We successfully established a rat model of myocardial I/R injury and observed an increase in FoxO4 expression in the myocardium. FoxO4 knockdown significantly protected rats from myocardial I/R injury, as indicated by a marked decrease in infarct sizes and improvements in cardiac function. Mechanistically, I/R induced excessive oxidative stress in rat hearts, most likely as a result of increased FoxO4 levels, and these effects contributed to inducing apoptosis. In conclusion, the FoxO4/ROS pathway represents a potentially novel mechanism underlying apoptosis during myocardial I/R injury. Therapeutic strategies targeting FoxO4 might represent new treatments for myocardial I/R injury.
Inhibition of Fibroblast IL-6 Production by ACKR4 Deletion Alleviates Cardiac Remodeling after Myocardial Infarction

Min Zhang,Ting Zhou,Meilin Liu,Ni Xia,Muyang Gu,Tingting Tang,Shaofang Nie,Zhengfeng Zhu,Bingjie Lv,Jiao,Xiangping Yang,Xiang Cheng

DOI: https://doi.org/10.1016/j.bbrc.2021.02.013

IF: 3.1

2021-01-01

Biochemical and Biophysical Research Communications

Abstract:Fibrotic scarring is tightly linked to the development of heart failure in patients with post-myocardial infarction (MI). Atypical chemokine receptor 4 (ACKR4) can eliminate chemokines, such as C-C chemokine ligand 21 (CCL21), which is independently associated with heart failure mortality. However, the role of ACKR4 in the heart during MI is unrevealed. This study aimed to determine whether ACKR4 modulates cardiac remodeling following MI and to illuminate the potential molecular mechanisms. The expression of ACKR4 was upregulated in the border/infarct area, and ACKR4 was predominantly expressed in cardiac fibroblasts (CFs). Knockout of ACKR4 protected against adverse ventricular remodeling in mice post-MI. These protective effects of ACKR4 deficiency were independent of dendritic cell immune response but could be attributed to downregulated CF-derived IL-6, affecting CF proliferation and endothelial cell (EC) functions, which consequently inhibited cardiac fibrosis. ACKR4 promoted IL-6 generation and proliferation of CFs. Besides, ACKR4 induced endothelial-to-mesenchymal transition (EndMT) in ECs through IL-6 paracrine effect. The p38 MAPK/NF-KB signaling pathway was involved in ACKR4 facilitated IL-6 generation. Moreover, ACKR4 overexpression in vivo via AAV9 carrying a periostin promoter aggravated heart functional impairment post-MI, which was abolished by IL-6 neutralizing antibody. Therefore, our study established a novel link between ACKR4 and IL-6 post-MI, indicating that ACKR4 may be a novel therapeutic target to ameliorate cardiac remodeling. (c) 2021 Elsevier Inc. All rights reserved.
FoxO, autophagy, and cardiac remodeling

Anwarul Ferdous,Pavan K Battiprolu,Yan G Ni,Beverly A Rothermel,Joseph A Hill

DOI: https://doi.org/10.1007/s12265-010-9200-z

Abstract:In response to changes in workload, the heart grows or shrinks. Indeed, the myocardium is capable of robust and rapid structural remodeling. In the setting of normal, physiological demand, the heart responds with hypertrophic growth of individual cardiac myocytes, a process that serves to maintain cardiac output and minimize wall stress. However, disease-related stresses, such as hypertension or myocardial infarction, provoke a series of changes that culminate in heart failure and/or sudden death. At the other end of the spectrum, cardiac unloading, such as occurs with prolonged bed rest or weightlessness, causes the heart to shrink. In recent years, considerable strides have been made in deciphering the molecular and cellular events governing pro- and anti-growth events in the heart. Prominent among these mechanisms are those mediated by FoxO (Forkhead box-containing protein, O subfamily) transcription factors. In many cell types, these proteins are critical regulators of cell size, viability, and metabolism, and their importance in the heart is just emerging. Also in recent years, evidence has emerged for a pivotal role for autophagy, an evolutionarily conserved pathway of lysosomal degradation of damaged proteins and organelles, in cardiac growth and remodeling. Indeed, evidence for activated autophagy has been detected in virtually every form of myocardial disease. Now, it is clear that FoxO is an upstream regulator of both autophagy and the ubiquitin-proteasome system. Here, we discuss recent advances in our understanding of cardiomyocyte autophagy, its governance by FoxO, and the roles each of these plays in cardiac remodeling.
Overexpression of zinc‐finger protein 418 inhibits pathological cardiac remodelling after acute myocardial infarction

Hongfei Jiang,Fei Lai,Xixing Wang,Fanqi Meng,Weiliang Zhu,Shan Huang

DOI: https://doi.org/10.1002/ehf2.14823

2024-05-08

ESC Heart Failure

Abstract:Aims Zinc‐finger protein 418 (ZNF418) has been confirmed to be expressed in myocardial tissue. However, the role and mechanism of ZNF418 in pathological myocardial remodelling after myocardial infarction (MI) have not been reported. This study was to elucidate the effect and mechanism of ZNF418 on ventricular remodelling after MI in mice. Methods and results MI mice and H9c2 cardiomyocytes were used to conduct in vivo and in vitro experiments, respectively. ZNF418 expression was regulated by adeno‐associated virus 9 and adenovirus vectors. Pathological analysis, echocardiography, and molecular analysis were performed. ZNF418 was down‐regulated in the left ventricular tissues of post‐MI mice. In contrast, ZNF418 overexpression decreased mortality and improved cardiac function in MI mice. The MI mice exhibited a significantly increased cross‐sectional area of myocardial cells and elevated protein expression levels of myocardial hypertrophy markers ANP, BNP, and β‐MHC (all P

cardiac & cardiovascular systems
CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY

Qiongxin Wang,Mohamed Ameen Ismahil,Yujie Zhu,Gregg Rokosh,Tariq Hamid,Guihua Zhou,Steven M. Pogwizd,Sumanth D. Prabhu

DOI: https://doi.org/10.1101/2024.10.01.24314741

2024-10-03

Abstract:BACKGROUND: Cardiac CD206+ macrophages expand acutely after myocardial infarction (MI) to promote wound healing; however, their role in chronic heart failure (HF) is unknown. We tested the hypothesis that cardiac CD206+ macrophages expressing interleukin(IL)-4Ralpha are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS AND RESULTS: Adult male C57BL/6 mice underwent non-reperfused MI to induce HF, or sham operation, and cardiac macrophages were profiled using flow cytometry. As compared to sham, CD206+ macrophages steadily expanded in post-MI hearts during LV remodeling, such that at 8 w post-MI they comprised ~85% of all macrophages. These macrophages were robustly proliferative and predominantly C-C motif chemokine receptor (CCR2)− and major histocompatibility complex (MHC)IIhi, with >90% of CD206+CCR2− macrophages expressing the resident macrophage marker LYVE-1. CD206+ macrophage abundance correlated with LV dysfunction and fibrosis. Nearly half of CD206+ macrophages expressed IL-4Ralpha, and the majority of CD206+IL-4Ralpha+ macrophages co-expressed the pro-fibrotic protein found in inflammatory zone (FIZZ)1. IL-4-polarized bone marrow derived CD206+ macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of cardiac mesenchymal stem cells (cMSCs), in part related to DLL-4/Jagged1-Notch1 signaling. Intramyocardial adoptive transfer of M[IL-4], but not M[IL-10], CD206+ macrophages to naive mice, induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Ralpha gene deletion in established HF (initiated 4 w post-MI) in IL-4Ralphaf/fLysM-CreERT2 mice significantly reduced CD206+ macrophage proliferation and effectively depleted CD206+IL-4Ralpha+ cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Ralpha gene silencing in mice with established HF effectively depleted cardiac CD206+IL-4Ralpha+ macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Lastly, alternatively activated CD206+ and CD163+ macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163+ macrophages expressed IL-4Ralpha and FIZZ3, the human homolog of FIZZ1. CONCLUSION: Cardiac CD206+IL-4Ralpha+ macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206+ macrophage IL-4Ralpha signaling alleviates LV remodeling in ischemic cardiomyopathy.

Cardiovascular Medicine

Abstract 13276: FoxO4 Promotes Post Myocardial Infarction Left Ventricular Remodeling

Abstract 261: Foxo4 Promotes Early Inflammatory Response Upon Myocardial Infarction Via Endothelial Arg1

The transcription factor foxo3 regulates cardiac remodeling after myocardial infarction

Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Abstract We130: Novel Role of RBFox1 in Myocardial Infarction Induced Heart Failure

Abstract 13152: Endothelial Foxp1 Regulates Cardiac Fibrosis Via Endothelial-To-Mesenchymal Transition

Abstract 516: Endothelial Foxp1 Regulates Cardiac Remodeling Via Tgfbeta and Et-1 Signal Pathway

Abstract 15392: Exosomal Microrna 486-5P Mediates Cardiac Angiogenesis Post Myocardial Infarction by Targeting MMP19 in Fibroblasts

Myoblast Transplantation Improves Cardiac Function after Myocardial Infarction Through Attenuating Inflammatory Responses.

Abstract 14348: Deleterious Effect of IL-23/IL-17A Axis and Γδt Cells in Left Ventricular Remodeling after Myocardial Infarction in Rodent

FOXO3a Induces Myocardial Fibrosis by Upregulating Mitophagy

Abstract 20446: Loss of Mir-144 Signaling Interrupts Extracellular Matrix Remodeling after Myocardial Infarction Leading to Worsened Cardiac Function

Abstract 15699: Matrix Metalloproteinase-9 Overexpression in Macrophages Improves Ventricular Function by Regulating the Inflammatory and Fibrotic Responses Post-Myocardial Infarction

The Structure-Function Remodeling In Rabbit Hearts Of Myocardial Infarction

A Novel Anti-inflammation and Anti-fibrosis Agent, Vcp979, Treatment Attenuates Ventricular Remodeling and Improves Cardiac Function in Murine Model of Myocardial Ischemia/Reperfusion Injury

Deleterious Effect of the Il-23/Il-17a Axis and Gamma Delta T Cells on Left Ventricular Remodeling after Myocardial Infarction

FoxO 4 Promotes Myocardial Ischemia-Reperfusion Injury : the Role of Oxidative Stress-Induced Apoptosis

Inhibition of Fibroblast IL-6 Production by ACKR4 Deletion Alleviates Cardiac Remodeling after Myocardial Infarction

FoxO, autophagy, and cardiac remodeling

Overexpression of zinc‐finger protein 418 inhibits pathological cardiac remodelling after acute myocardial infarction

CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY